Circumventing challenges in mitochondrial targeting for cancer treatment: leveraging nanoplatforms for effective solutions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Circumventing challenges in mitochondrial targeting for cancer treatment: leveraging nanoplatforms for effective solutions

Published:2024 Issue:2 Volume:5 Page:409-431
ISSN:2633-5409
Container-title:Materials Advances
language:en
Short-container-title:Mater. Adv.

Author:

Pandya Shivani R.¹²^ORCID,Singh Harjeet¹²,Desimone Martin F.³,Singh Jagpreet⁴^ORCID,George Noble¹²,Jasani Srushti¹

Affiliation:

1. Research and Development Cell, Parul university, Vadodara, Gujarat, India

2. Parul Institute of Applied Sciences, Parul University, Vadodara, Gujarat, India

3. Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Instituto de Química y Metabolismo del Fármaco (IQUIMEFA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina

4. University Centre for Research and Development (UCRD), Chandigarh University, Mohali, Punjab, India

Abstract

Cancer is a highly complex disease that affects lives and causes millions of deaths worldwide.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Chemistry (miscellaneous)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/MA/D3MA00629H

Reference215 articles.

1. Nat. Cancer , 2020 , 1 , 12

2. Cancer statistics for the year 2020: An overview

3. Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics

4. Epidemiology of Prostate Cancer

5. A recurrent mutation in PALB2 in Finnish cancer families

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP